Randox Laboratories Ltd. UK in
association with UK Trade and Investment Pakistan organised seminars in
Karachi, Lahore and Islamabad from 22nd to 24th May, on “Improving Healthcare
and Laboratory performance in Pakistan.”
The seminars were targeted to
the pathologists and lab professionals of private and public hospitals in
Pakistan.
Stephen Doherty, a
representative of Randox Laboratories Ltd, was the key note speaker with his
main topic of discussion being how hospitals and laboratories in Pakistan can
improve patients’ results reported by the clinical laboratories through
External Quality Assurance and Internal Quality Control.
Dr. Adnan Zuberi, a Consultant Chemical Pathologist at Ziauddin
University Hospital, also was one of the speaker’s during the seminars who
discussed the cost saving benefits of early errors detection and correct
patient diagnosis.
Randox Laboratories Ltd was established in 1982 in the UK and for over
30 years they have played a pioneering role in healthcare. Today, as a world
leader in in-vitro diagnostics, they
supply a wide range of diagnostic instruments and tests for rapid and reliable
disease detection. Randox have been distributing in Pakistan through Muslim
Trading for almost 25 years and have established business with both public and
private sector healthcare customers.
British
Deputy High Commissioner and Director UK Trade and Investment, Pakistan,
Francis Campbell said:
“We
are very pleased to organise these seminars with Randox to improve healthcare
system in Pakistan. UK Trade and Investment’s main role in Pakistan is to help
British business grow and Randox’s success in this market sets up a fine
example of successful British companies operating in Pakistan.”
No comments:
Post a Comment